Mitoxantrone in acute lymphoblastic leukemia.
作者信息
Paciucci P A, Ohnuma T, Cuttner J, Silver R T, Holland J F
出版信息
Cancer Treat Rev. 1983 Dec;10 Suppl B:65-8. doi: 10.1016/0305-7372(83)90025-7.
PMID:6581869
Abstract
摘要
相似文献
1
Mitoxantrone in acute lymphoblastic leukemia.
Cancer Treat Rev. 1983 Dec;10 Suppl B:65-8. doi: 10.1016/0305-7372(83)90025-7.
2
Mitoxantrone--a critique.
Cancer Treat Rev. 1983 Dec;10 Suppl B:77-9. doi: 10.1016/0305-7372(83)90028-2.
3
Mitoxantrone in malignant lymphomas.
Cancer Treat Rev. 1983 Dec;10 Suppl B:69-72. doi: 10.1016/0305-7372(83)90026-9.
4
Sequential studies on the role of mitoxantrone in the treatment of acute leukaemia.
Cancer Treat Rev. 1983 Dec;10 Suppl B:57-63. doi: 10.1016/0305-7372(83)90024-5.
5
Mitoxantrone versus doxorubicin in advanced breast cancer: a randomized cross-over trial.米托蒽醌与阿霉素治疗晚期乳腺癌的随机交叉试验
Cancer Treat Rev. 1983 Dec;10 Suppl B:41-6. doi: 10.1016/0305-7372(83)90021-x.
6
Mitoxantrone as first line cytotoxic therapy in advanced breast cancer: preliminary results of a phase II study.米托蒽醌作为晚期乳腺癌一线细胞毒性治疗：一项II期研究的初步结果。
Cancer Treat Rev. 1983 Dec;10 Suppl B:47-52. doi: 10.1016/0305-7372(83)90022-1.
7
Mitoxantrone (novantrone): a review of experimental and early clinical studies.
Cancer Treat Rev. 1983 Jun;10(2):103-15. doi: 10.1016/0305-7372(83)90008-7.
8
Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
Invest New Drugs. 1985;3(2):203-6. doi: 10.1007/BF00174171.
9
Mitoxantrone.米托蒽醌
Cancer Treat Rev. 1984 Dec;11(4):289-93. doi: 10.1016/0305-7372(84)90025-2.
10
Clinical safety and tolerance of mitoxantrone (Novantrone).米托蒽醌（诺维本）的临床安全性与耐受性。
Cancer Treat Rev. 1983 Dec;10 Suppl B:29-36. doi: 10.1016/0305-7372(83)90019-1.
引用本文的文献
1
Zotero 插件